A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)

Summary

This is a long-term extension study that will rollover participants completing feeder studies IMVT-1402-2502 (NCT06727604) or IMVT-1402-2503 (NCT07018323) to evaluate the efficacy and safety of IMVT-1402 in adult participants with GD. Eligible participants will be assigned to 1 of 3 study groups (Groups A, B and C) based on their GD status at the completion of their respective feeder study.

Timeline

Start

2026-01-26

Primary completion

2030-03

Completion

2030-03

Drugs

Indications